HIPAA
HIPAA Penetration Testing and Risk Analysis
The Security Rule never uses the phrase penetration testing. It requires a risk analysis and a periodic technical evaluation, and testing is how most organisations evidence the second of those.
- Accurate about what the Security Rule actually says
- Findings written to feed your risk analysis
- Scoped around systems touching PHI
What the Security Rule requires
Two provisions matter for testing. The risk analysis requirement asks for an accurate and thorough assessment of risks and vulnerabilities to electronic protected health information. The evaluation requirement asks for periodic technical and non-technical evaluation of whether your safeguards continue to meet the rule.
Neither names penetration testing. Both are difficult to satisfy credibly without technical testing of some kind, which is why testing has become the conventional answer. But precision matters here: if a vendor tells you HIPAA mandates a penetration test, they are describing marketing rather than regulation, and it is reasonable to wonder what else they are approximating.
Why testing still matters for HIPAA
A risk analysis based only on questionnaires and documentation describes the system you believe you have. Regulators and plaintiffs are interested in the system you actually have. Technical testing is what connects the two, and a risk analysis supported by demonstrated findings is substantially more defensible than one built from interviews.
The addressable-versus-required structure of the rule also means you must document reasoning about which safeguards you implemented and why. Testing evidence is what makes that reasoning credible rather than assertive.
How we scope a HIPAA-driven engagement
Scope follows the data. We map where electronic protected health information is created, received, maintained and transmitted, then test the systems on that path. This routinely produces a wider scope than teams expect, because PHI reaches places nobody intended.
- Application and API layers handling clinical or patient data
- Integration points with providers, payers, laboratories and clearing houses
- Access control between roles — clinician, administrator, billing, support — which is where the highest-impact findings usually sit
- Audit logging sufficient to reconstruct who accessed which record
- Encryption in transit and at rest, plus the places PHI leaks in cleartext: logs, analytics, exports, support tooling and backups
- Business associate integrations, where your obligations continue into someone else's system
The finding pattern in healthcare systems
In our experience the dominant risk in healthcare platforms is not an injectable parameter. It is authorisation: a clinician reaching records outside their assigned patients, a support role able to view clinical detail it needs no access to, or an export function that ignores the filtering applied in the interface. These map directly onto the access control provisions of the rule and are invisible to automated scanning.
What you receive
- Findings framed against the Security Rule safeguards they relate to, so they drop into your risk analysis
- An assessment of whether audit controls would let you reconstruct access to a specific record
- A map of where PHI travels outside the systems you consider in scope
- Remediation guidance written for engineers, with the compliance consequence stated separately
- Retest evidence for corrected findings
Common questions
Does HIPAA require a penetration test?
No. The Security Rule requires a risk analysis and a periodic technical and non-technical evaluation of your safeguards. It does not name penetration testing. Testing is the most common and most defensible way to evidence the evaluation requirement and to ground the risk analysis in reality, but it is a means rather than a mandate.
How often should a HIPAA-covered entity test?
The rule says periodically without setting an interval. Annually, plus after significant change to systems handling protected health information, is the convention that regulators and auditors accept. If you release frequently, testing between annual assessments is a better match for your actual risk profile.
Do you sign a Business Associate Agreement?
Where an engagement gives us access to protected health information, a Business Associate Agreement is appropriate and we will execute one. In many engagements it can be avoided entirely by testing against synthetic data, which we prefer where it does not reduce the quality of the test. We will raise this during scoping rather than after.
Does HIPAA apply to us if we are outside the United States?
It can. The obligation follows the data and the relationship, not your location: if you handle protected health information on behalf of a covered entity, you are a business associate and the Security Rule applies to you through your agreement. Indian development and support firms working for US healthcare clients are frequently in exactly this position.
Do you test against synthetic patient data?
Wherever it does not weaken the test, and for HIPAA work that is usually possible. Synthetic records with realistic structure across multiple patients, clinicians and roles produce the same authorisation findings as real data. It also avoids a Business Associate Agreement being necessary at all, which is simpler for both of us.
What is the most common serious finding in healthcare platforms?
Authorisation, by a wide margin. A clinician able to open records outside their assigned patients, a support or billing role with visibility into clinical detail it has no need for, or an export that ignores the filtering enforced in the interface. These map directly onto the access control and audit provisions of the rule and no scanner will find them.
Does our audit logging satisfy the HIPAA audit controls requirement?
That is one of the things worth testing rather than assuming. The requirement is to record and examine activity in systems holding protected health information, which in practice means being able to reconstruct who accessed a specific record and when. Many systems log application errors thoroughly and record data access barely at all.
Let's scope your infrastructure.
Tell us what you have built and what you are testing against. You will speak to a Lead Security Architect, not a sales desk, and you will get a written scope with a fixed price before any work begins.